Lifesci Capital Analysts Lift Earnings Estimates for Lucira Health, Inc. (NASDAQ:LHDX)

Lucira Health, Inc. (NASDAQ:LHDX – Get Rating) – Stock analysts at Lifesci Capital increased their Q3 2022 EPS estimates for Lucira Health in a research report issued to clients and investors on Wednesday, September 28th. Lifesci Capital analyst R. Rakhit now expects that the company will earn ($0.19) per share for the quarter, up from […]